PARIS, Oct. 11, 2022 /PRNewswire/ Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for cancer and inflammatory diseases based on its unique Mimicry platform
Our new name "Molecure" reflects expansion of scope of small molecule targets from novel proteins to mRNA in discovery & development of breakthrough therapies.
/PRNewswire/ Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment.
/PRNewswire/ Pneumagen, a clinical stage biotech company developing Neumifil, an intranasal, broad-spectrum antiviral treatment to prevent or, if infected.
/PRNewswire/ Molecure S.A. ("Molecure": WSE: MOC) a clinical stage biotechnology company that uses its world leading medicinal capabilities to discover and.